{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:18:37Z","timestamp":1793056717771,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jinf.2024.106246","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T17:18:54Z","timestamp":1723137534000},"page":"106246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants"],"prefix":"10.1016","volume":"89","author":[{"given":"Holly A.","family":"Fryer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Geers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennert","family":"Gommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca M.","family":"Zaeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4613-7865","authenticated-orcid":false,"given":"Bernadette","family":"Jones-Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-6217","authenticated-orcid":false,"given":"Abraham","family":"Goorhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe F.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Mark","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion P.G.","family":"Koopmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine H.","family":"GeurtsvanKessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn E.","family":"O\u2019Hehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Hugo M.","family":"van der Kuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory D.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno C.","family":"van Zelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2024.106246_bib1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106246_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2024.106246_bib3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106246_bib4","unstructured":"World Health Organization. Statement on the antigen composition of COVID-19 vaccines; 2023 Vol. 2023."},{"key":"10.1016\/j.jinf.2024.106246_bib5","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1016\/j.vaccine.2023.10.021","article-title":"Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1\/BA.2 and BA.5 in Japan","volume":"41","author":"Arashiro","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2024.106246_bib6","unstructured":"Australian Government Department of Health. ATAGI recommendations on the use of a booster dose of COVID-19 vaccine; 2022. Vol. 2022."},{"key":"10.1016\/j.jinf.2024.106246_bib7","unstructured":"Australian Government Department of Health. ATAGI recommendations on use of the Pfizer bivalent (Original\/Omicron BA.4\/5) COVID-19 vaccine; 2023. Vol. 2023."},{"key":"10.1016\/j.jinf.2024.106246_bib8","unstructured":"European Medicines Agency. ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines; 2022."},{"key":"10.1016\/j.jinf.2024.106246_bib9","unstructured":"Australian Government Department of Health ATAGI recommendations on use of the Pfizer bivalent (Original\/Omicron BA.1) COVID-19 vaccine; 2022. Vol. 2023."},{"key":"10.1016\/j.jinf.2024.106246_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A bivalent Omicron-containing booster vaccine against Covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106246_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162192","article-title":"Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity","volume":"133","author":"Aguilar-Bretones","year":"2023","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jinf.2024.106246_bib12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1473-3099(23)00122-6","article-title":"Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study","volume":"23","author":"Arbel","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106246_bib13","article-title":"Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged \u226550 years in Nordic countries: nationwide cohort study","volume":"382","author":"Andersson","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2024.106246_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nature Med"},{"key":"10.1016\/j.jinf.2024.106246_bib15","article-title":"Safety and immunogenicity of XBB.1.5-Containing mRNA vaccines","author":"Chalkias","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.jinf.2024.106246_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A bivalent Omicron-containing booster vaccine against Covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106246_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06025-4","article-title":"SARS-CoV-2 Omicron boosting induces de novo B cell response in humans","volume":"617","author":"Alsoussi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2024.106246_bib18","doi-asserted-by":"crossref","first-page":"2270069","DOI":"10.1080\/22221751.2023.2270069","article-title":"Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3","volume":"12","author":"Faraone","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jinf.2024.106246_bib19","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.immuni.2021.09.011","article-title":"mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants","volume":"54","author":"Sokal","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jinf.2024.106246_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41467-021-21444-5","article-title":"Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19","volume":"12","author":"Wheatley","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2024.106246_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.medj.2021.02.001","article-title":"Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6 months after the infection","volume":"2","author":"Sherina","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.jinf.2024.106246_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1056\/NEJMc2214293","article-title":"Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster","volume":"388","author":"Davis-Gardner","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2024.106246_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41591-022-02092-8","article-title":"Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice","volume":"29","author":"Scheaffer","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2024.106246_bib24","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1038\/s41467-024-48414-x","article-title":"Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters","volume":"15","author":"Zaeck","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2024.106246_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib26","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3390\/cells10102541","article-title":"Highly specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA","volume":"10","author":"Piano Mortari","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jinf.2024.106246_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf8891","article-title":"Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence","volume":"5","author":"Hartley","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.15624","article-title":"The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2","volume":"78","author":"Hartley","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jinf.2024.106246_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jinf.2024.106246_bib30","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s10875-023-01527-2","article-title":"COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants","volume":"43","author":"Fryer","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41541-024-00919-8","article-title":"Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding","volume":"9","author":"Hartley","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jinf.2024.106246_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1067749","article-title":"Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: the SWITCH ON trial protocol","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib33","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3389\/fimmu.2019.02593","article-title":"Predominantly antibody-deficient patients with non-infectious complications have reduced Naive B, Treg, Th17, and Tfh17 Cells","volume":"10","author":"Edwards","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1473-3099(23)00140-8","article-title":"Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial","volume":"23","author":"Tan","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2024.106246_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.11.029","article-title":"Functional SARS-CoV-2-specific immune memory persists after mild COVID-19","volume":"184","author":"Rodda","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2024.106246_bib36","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ni.3533","article-title":"Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination","volume":"17","author":"Ellebedy","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib37","doi-asserted-by":"crossref","first-page":"eaai8153","DOI":"10.1126\/sciimmunol.aai8153","article-title":"Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation","volume":"2","author":"Lau","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib38","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1182\/blood-2011-04-345579","article-title":"Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways","volume":"118","author":"Berkowska","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2024.106246_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1020844","article-title":"mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine","volume":"13","author":"Buhre","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib41","unstructured":"outbreak.info. BQ.1.1 Lineage Report; 2023. Vol. 2023. outbreak.info."},{"key":"10.1016\/j.jinf.2024.106246_bib42","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1038\/s41467-023-38435-3","article-title":"The genotype to phenotype Japan, virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants","volume":"14","author":"Tamura","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2024.106246_bib43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41541-023-00708-9","article-title":"Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4\/BA.5) increases neutralization of matched Omicron variants","volume":"8","author":"Springer","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jinf.2024.106246_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38077-x","article-title":"The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response","volume":"13","author":"Hein","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2024.106246_bib45","doi-asserted-by":"crossref","first-page":"2270071","DOI":"10.1080\/22221751.2023.2270071","article-title":"Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination","volume":"12","author":"Suryawanshi","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jinf.2024.106246_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi8039","article-title":"AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans","volume":"9","author":"Grigoryan","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355949","article-title":"SARS-CoV-2 spike-reactive na\u00efve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination","volume":"15","author":"Teng","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110164","article-title":"Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals","volume":"261","author":"Galeota","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chom.2023.11.012","article-title":"Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jinf.2024.106246_bib50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.immuni.2024.02.016","article-title":"Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans","volume":"57","author":"Tortorici","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jinf.2024.106246_bib51","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1084\/jem.20110740","article-title":"Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants","volume":"208","author":"Purtha","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jinf.2024.106246_bib52","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.immuni.2023.07.007","article-title":"SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals","volume":"56","author":"Sokal","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jinf.2024.106246_bib53","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","article-title":"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination","volume":"185","author":"R\u00f6ltgen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2024.106246_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2024.106246_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00105-2","article-title":"Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T cells recognise the omicron XBB sublineage","volume":"4","author":"Traut","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jinf.2024.106246_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/imr.12094","article-title":"How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth","volume":"255","author":"Baumgarth","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jinf.2024.106246_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46025-y","article-title":"XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants","volume":"13","author":"Patel","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2024.106246_bib58","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.immuni.2024.02.016","article-title":"Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans","volume":"57","author":"Tortorici","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jinf.2024.106246_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41541-023-00724-9","article-title":"Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells","volume":"8","author":"Krause","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jinf.2024.106246_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.535784","article-title":"The antigen presenting potential of CD21low B cells","volume":"11","author":"Reincke","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib61","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2024.106246_bib62","unstructured":"World Health Organization. Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine; 2022. COVID-19: Vaccin Vol. 2024."},{"key":"10.1016\/j.jinf.2024.106246_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41541-021-00369-6","article-title":"Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action","volume":"6","author":"Heinz","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jinf.2024.106246_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf1421","article-title":"SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines","volume":"7","author":"Bowen","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jinf.2024.106246_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jinf.2024.106246_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients","volume":"6","author":"Geers","year":"2021","journal-title":"Sci Immunol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445324001804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T08:29:27Z","timestamp":1729585767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445324001804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0163445324001804"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106246","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106246"}}